MDMA Neurotoxicity Studies in Primates: Dose-Response and Serotonergic Damage

A review of preclinical studies indicates monkeys are more sensitive than rats to the serotonin-depleting effects of MDMA. The research, authored by G.A. Ricaurte of Johns Hopkins University, shows a toxic dose of 5 mg/kg in monkeys closely approaches typical human recreational doses of 1.7 to 2.7 mg/kg. These findings suggest a narrow safety margin and heighten concern for potential long-term neurotoxic effects in humans.

Use Cases

• Modeling dose-response relationships for MDMA neurotoxicity based on the described steep curve in primates.
• Comparing interspecies sensitivity to serotonergic damage based on the described differences between monkeys and rats.
• Investigating biomarkers for neurotoxicity based on the described use of CSF 5-HIAA to detect serotonergic damage.
• Assessing safety margins for recreational drug use based on the described proximity of toxic doses in monkeys to typical human doses.

Strengths

• Provides specific dose comparisons: 5 mg/kg toxic dose in monkeys versus 1.7-2.7 mg/kg typical human dose.
• Describes a clear interspecies difference in sensitivity and anatomical targets (nerve fibers vs. cell bodies).
• Identifies a potential biomarker (CSF 5-HIAA) for detecting serotonergic damage.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

G.A. Ricaurte, Johns Hopkins University

Collection Method

Review of preclinical studies, likely involving experimental administration of MDMA to nonhuman primates.